An arthrogram is an x-ray fluoroscopy of a joint performed with a sequential digital subtracted spot films after injection of a contrast agent.

See Arthrography.

In June 2006 Bayer AG has bought the majority of shares of Schering AG. As a result of this take-over Schering AG has been renamed in December 2006 in Bayer Schering Pharma AG. The Bayer Schering Pharma AG is part of the Bayer HealthCare AG, which represents the pharmaceutical part of the Bayer Group.
Berlex Laboratories (USA) and Berlex Canada Inc., former affiliates of Schering AG, have been integrated into Bayer HealthCare and operate as a specialty pharmaceuticals business that also sells MRI contrast agents, under the name Bayer HealthCare Pharmaceuticals, which is a subsidiary of Bayer Schering Pharma AG.

The company is developing and making specialized medicines for treating multiple sclerosis, dermatological disorders, female health concerns, cancer and is creating new diagnostic imaging techniques. Berlex, Inc. is a pioneer in the imaging market. It has introduced a broad range of imaging agents. Its contribution began in 1988 with the introduction of the world's first magnetic resonance imaging agent, Magnevist® (gadopentetate dimeglumine) injection. Berlex is headquartered in New Jersey and the U.S. affiliate of Bayer Schering Pharma AG, Germany.

The brightness is the balance of light and dark shades in a displayed image. High brightness (also called density or intensity) settings produce bright images and low settings produce dark images. The contrast determines how many gray levels are displayed and the density determines the intensity.

The cardiac catheterization requires the passage of a small catheter through an arm or leg vessel into the heart, in order to permit the securing of blood samples, determination of intracardiac pressure, detection of cardiac anomalies, and injection of contrast media for angiography.